Qiming Venture Partners

Qiming Venture Partners, established in 2006, is a leading China-based venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, and Singapore. It manages multiple funds totaling $9.5 billion, focusing on early and growth-stage investments in the Technology and Consumer (T&C) and Healthcare industries. With a strong track record, over 200 portfolio companies have achieved exits, and over 70 have become unicorns or super unicorns. Qiming Venture Partners USA, founded in 2017, is its affiliate in Cambridge, Massachusetts, specializing in healthcare, therapeutics, and digital health investments. The firm is known for its deep technical expertise, hands-on operational support, and thought leadership in the venture capital industry.

Zhang Ao

Executive Director

Artavazd Arumov Ph.D

Principal

Ryan Baker

CFO

Cyrus Chan

Associate

Nan Chen

Principal

David Chu

Partner

Isaac Ciechanover

Partner

Phil DiGiacomo

Principal

Anna French

Managing Partner

Yuxin Fu

Vice President

Jinda Gao

Principal

Kuantai Yeh

Partner

Robert Headley

Partner

Maykin Ho

Venture Partner

William Hu

Managing Partner

Duane Kuang

Co-Founder and Managing Partner

Nisa Leung

Managing Partner

Dingzheng Li

Vice President

Jing Liu

Vice President

Chang Liu

Associate

Bin Liu

Vice President

Biao Lu

Associate

Shuo Mao

Principal

Will McConnell

Principal

Gary Rieschel

Founder and Managing Partner

James Shen

Venture Partner

Motao Sun

Vice President

Amy Tang

Venture Partner

Yi Tang

Principal

Shiyu Wang

Partner

Rachel Wang

Venture Partner

James Wang

Venture Partner

Gillian Xu

RMB funds CFO

Peter (Ming) Yin

Principal, Cleantech

Janet Yu

Partner

Oscar Zhang

Principal

Yafeng Zhou

Associate

Alex Zhou

Managing Partner

Zhiyuan Zhou

Associate

Zhifeng Zhou

Managing Partner

Jing-Shan Hu Ph.D

Venture Partner of Healthcare

Phillip DiGiacomo Ph.D

Principal

Past deals in Artificial Intelligence

iflybuds

Seed Round in 2025
Vision Intelligence is a AI smart hardware company that manufactures and sells interactive intelligence based electronic consumer products.

TARS

Angel Round in 2025
Zhihang Zhong is a prominent researcher in the field of artificial intelligence, particularly known for his work on integrating spatial perception and reasoning into AI systems.

Force Inspiration

Angel Round in 2025
Force Inspiration is a start-up focusing on embodied intelligence technology. The company mainly engages in technology development, technical consulting, software development, basic artificial intelligence software development, information system integration services, intelligent robot research and development and sales, and industrial robot manufacturing and sales.

DH-Robotics

Venture Round in 2025
DH Robotics Technology Co., Ltd., founded in 2016 and based in China, specializes in the research and development of robotic hands and industrial robots. The company focuses on creating electric gripping jaws intended to enhance intelligent manufacturing processes. Its products are designed to be stable, secure, and easily integrated, catering to the needs of advanced manufacturing and lean production. By developing cost-effective solutions, DH Robotics aims to support flexible and intelligent demands within the manufacturing sector.

MiGuo AI

Angel Round in 2025
Miguo AI enhances artificial intelligence in various industries and transforms visual content creation.

Xi'an Dunbo Medical Equipment

Series A in 2025
Xi'an Dunbo Medical Equipment focuses on the research, development, and production of AI medical devices. The products currently under development are cardiac pacemakers and brain pacemakers, Cardiac defibrillators. Self-developed products include chips, hardware circuits, software application systems, and structural materials.

StepStar

Series B in 2024
The goal of Stepstar is to "Ten Times the Possibility of Everyone" through Intelligent Step. Step Star firmly creates its own super model and actively uses important resources like

Zhipu AI

Venture Round in 2024
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

Tianhu Technology

Series A in 2024
Tianhu Technology provides drug research and development services through independent collaborative closed-loop iterations, deeply integrating AI solutions with the drug development and production process. Tianhu Technology is an innovative drug R&D company that offers high-throughput phenotypic screening and physical computing technology, as well as AI solutions that are deeply integrated into the drug R&D process.

Matwings Technology

Series A in 2024
Matwings Technology is a biotechnology company that specializes in the design of functionally optimized proteins using advanced evolutionary methods. It focuses on the development of innovative drug molecular design through computational chemistry and artificial intelligence. Matwings collaborates with major pharmaceutical companies to conduct early-stage research and development of drugs targeting complex clinical challenges. The company's goal is to achieve breakthroughs in drug targets that are typically difficult to formulate, emphasizing the clinical value of its innovations.

Bioyond Tech

Series A in 2024
Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

Zhipu AI

Series D in 2024
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

Infinigence

Series A in 2024
Infinigence is dedicated to providing AGI computing power solutions based on its large model energy efficiency optimization tools, with the goal of resolving the challenge of efficient and unified deployment of large model algorithms to large computing power chips.

TandemAI

Series C in 2024
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven, high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution.

Thorough Future

Series A in 2024
Thorough Future specializes in the integration of advanced technology within the medical sector, focusing on enhancing diagnostic services in clinical medicine. The company leverages artificial intelligence and big data to offer intelligent diagnosis and predictive services for pathology images. This innovative approach aims to improve diagnostic accuracy and efficiency, particularly for cancer patients, by providing personalized treatment recommendations. Through its commitment to integrating cutting-edge technology into healthcare, Thorough Future seeks to transform the way medical diagnoses are conducted and treatments are tailored.

Shengshu Technology

Venture Round in 2024
Shengshu Technology specializes in generative artificial intelligence infrastructure, focusing on the development of multi-modal large-scale models that integrate various forms of information, including text, images, videos, and 3D content. The company offers a sophisticated 3D image generator that employs Multi-Modal Diffusion models based on transformers. This technology allows clients in design, game production, and post-production to create images tailored to their specific requirements regarding composition, style, and precision.

Zhipu AI

Series B in 2024
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

Shengshu Technology

Seed Round in 2024
Shengshu Technology specializes in generative artificial intelligence infrastructure, focusing on the development of multi-modal large-scale models that integrate various forms of information, including text, images, videos, and 3D content. The company offers a sophisticated 3D image generator that employs Multi-Modal Diffusion models based on transformers. This technology allows clients in design, game production, and post-production to create images tailored to their specific requirements regarding composition, style, and precision.

Pinnacle Medicines

Series A in 2024
Pinnacle Medicines is a peptide drug discovery company located in Doylestown, Pennsylvania. The company specializes in developing peptide-based therapeutics to address unmet medical needs. Utilizing AI-driven drug design tools, Pinnacle Medicines focuses on creating safe and effective treatments for medical applications. Through its innovative approach, the company aims to enhance the availability of convenient and reliable therapeutics for various health challenges.

DH-Robotics

Series C in 2024
DH Robotics Technology Co., Ltd., founded in 2016 and based in China, specializes in the research and development of robotic hands and industrial robots. The company focuses on creating electric gripping jaws intended to enhance intelligent manufacturing processes. Its products are designed to be stable, secure, and easily integrated, catering to the needs of advanced manufacturing and lean production. By developing cost-effective solutions, DH Robotics aims to support flexible and intelligent demands within the manufacturing sector.

Leapstack

Series C in 2023
Leapstack is an insurance technology company based in Shanghai, with additional offices in Beijing and Nanjing. Founded in February 2016, it focuses on developing big data artificial intelligence solutions tailored for commercial insurance companies and social security management agencies. The company's platform enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, anti-fraud measures, and compliance identification. By addressing inefficiencies in the industry, Leapstack aims to improve operational effectiveness and provide comprehensive data analysis and management tools for its clients.

ABUP

Series B in 2023
ABUP specializes in over-the-air (OTA) solutions for the automotive and Internet of Things (IoT) sectors. The company offers a range of products and services, including firmware upgrades, software upgrades, and cloud diagnosis for automobiles, as well as IoT upgrade solutions. By leveraging artificial intelligence and big data, ABUP enables its customers to keep their products current, ensuring users benefit from a tailored experience and ongoing innovation. Their technology supports original equipment manufacturers by providing comprehensive OTA system solutions that enhance product management and upgrades in the rapidly evolving IoT landscape.

Yanyin Technology

Seed Round in 2023
Yanyin Technology provides AI solutions and scientific research collaboration platforms for biomedical field.

Prime Lifescience

Seed Round in 2023
Prime Lifescience is a developer of a big data platform tailored for the life sciences sector. The company focuses on creating a health lifecycle big data collaboration network through innovative digital technologies and the application of artificial intelligence. Prime Lifescience offers a range of services, including a digital smart health community, a digital intelligent clinical research accelerator, and a live big data platform. These offerings aim to enhance digital clinical research and foster a comprehensive medical solutions framework within the healthcare industry, leveraging extensive data to improve health outcomes.

Infinigence

Series A in 2023
Infinigence is dedicated to providing AGI computing power solutions based on its large model energy efficiency optimization tools, with the goal of resolving the challenge of efficient and unified deployment of large model algorithms to large computing power chips.

Shennapsi Artificial Intelligence Technology

Series A in 2023
Synapsor is a medical-grade wearable device research and development company, oriented to the AI+ medical and health field, and is committed to the development and manufacturing of AI-powered medical-grade smart wearable devices, including AI-ECG artificial intelligence. Diagnostic analysis system, CUMS uric acid blood glucose and cholesterol monitoring system, etc. The company has recently received tens of millions of yuan in Series B investment, and the investor is Xiaomi Technology.

Huimei Technology

Series D in 2023
Huimei Technology is a National high-tech enterprise that offers medical artificial intelligence solutions.

Inexbot

Series A in 2023
iNexBot specializes in the development and manufacturing of robot motion controllers and industrial robot intelligence technology. The company focuses on creating solutions for various sectors, including industrial robotics, collaborative robotics, semiconductors, healthcare automation, and automotive electronics. iNexBot's offerings encompass advanced robot motion control systems, machine vision technology, laser seam tracking technology, and other essential robot hardware. By providing both hardware and software, iNexBot equips robot manufacturers with the necessary tools to enhance their robotic products and improve operational efficiency across multiple industries.

Solo Music

Series B in 2023
Solo Music is an AI-based music education platform that provides online education services for several musical instruments.

Zhipu AI

Series B in 2023
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

Thorough Future

Series A in 2023
Thorough Future specializes in the integration of advanced technology within the medical sector, focusing on enhancing diagnostic services in clinical medicine. The company leverages artificial intelligence and big data to offer intelligent diagnosis and predictive services for pathology images. This innovative approach aims to improve diagnostic accuracy and efficiency, particularly for cancer patients, by providing personalized treatment recommendations. Through its commitment to integrating cutting-edge technology into healthcare, Thorough Future seeks to transform the way medical diagnoses are conducted and treatments are tailored.

HOUMO.AI

Series A in 2023
Houmo.AI is a semiconductor company founded in 2020 by Dr. Wu Qiang, specializing in integrated circuit storage technology tailored for artificial intelligence and high-power computing applications. The company focuses on developing intelligent computing chips that cater to the growing demand for computing power in the AI sector. By leveraging innovative technologies, Houmo.AI aims to deliver chips that offer significant performance improvements while maintaining low power consumption and affordability. This approach enables enterprises to manufacture advanced intelligent robotics and other AI-integrated electronics, ultimately striving to meet the challenges of true artificial intelligence.

Zeen Health

Series A in 2023
Zeen Health is a digital therapeutics company that specializes in providing personalized mental health services through a mobile application. Founded in 2019 and headquartered in Shenzhen, China, the company utilizes artificial intelligence technology to deliver evidence-based mental health solutions. By focusing on the individual needs of users, Zeen Health aims to improve mental wellness through innovative digital approaches.

Bioyond Tech

Series A in 2023
Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

Qianshou

Series A in 2023
Qianshou is a dating application that helps to find the right partner for life by using artificial matchmaker service.

Deepway

Series A in 2023
Deepway is a manufacturer of smart vehicles focused on the truck freight market, offering advanced intelligent driving solutions. The company designs heavy-duty trucks characterized by low wind resistance and high-level intelligent driving capabilities. Its vehicles feature a distributed drive system with a modular design that operates on a unified hydrogen and electricity platform. This innovative approach allows the logistics industry to leverage smart freight systems, enhancing efficiency and sustainability in transportation.

TandemAI

Series A in 2023
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure. The company integrates proprietary AI-driven, high-performance computation with its efficient, large-scale in-house wet lab operations to deliver a turnkey drug discovery solution.

Frontis

Angel Round in 2023
Frontis provides artificial intelligence technology solutions focused on demand planning and product performance monitoring. The company specializes in 3C product planning, marketing strategies, and digital transformation services, catering primarily to the fast-moving consumer goods (FMCG), 3C, and beauty sectors. By leveraging advanced technology, Frontis aids businesses in forecasting product demand and understanding consumer needs, thereby enhancing their ability to connect with customers and create value.

Biotree Technology

Series A in 2023
Biotree is a high-tech enterprise focused on the application and development of advanced research technology in the life sciences sector. It specializes in metabolomics, offering early detection and analysis services in China. The company boasts a core team with significant expertise in metabolomics, encompassing scientific research services, health testing, and industrial testing. Biotree emphasizes mass spectrometry and metabolic testing, continually innovating in metabolomics products and technologies. It holds several patents in this field and is recognized for its accomplishments in metabolomics detection and analysis. Over the years, Biotree has demonstrated consistent growth and has maintained profitability for six consecutive years, solidifying its position in the biotechnological testing and consulting services market.

Shennapsi Artificial Intelligence Technology

Series A in 2022
Synapsor is a medical-grade wearable device research and development company, oriented to the AI+ medical and health field, and is committed to the development and manufacturing of AI-powered medical-grade smart wearable devices, including AI-ECG artificial intelligence. Diagnostic analysis system, CUMS uric acid blood glucose and cholesterol monitoring system, etc. The company has recently received tens of millions of yuan in Series B investment, and the investor is Xiaomi Technology.

Thorough Future

Series A in 2022
Thorough Future specializes in the integration of advanced technology within the medical sector, focusing on enhancing diagnostic services in clinical medicine. The company leverages artificial intelligence and big data to offer intelligent diagnosis and predictive services for pathology images. This innovative approach aims to improve diagnostic accuracy and efficiency, particularly for cancer patients, by providing personalized treatment recommendations. Through its commitment to integrating cutting-edge technology into healthcare, Thorough Future seeks to transform the way medical diagnoses are conducted and treatments are tailored.

Deepway

Series A in 2022
Deepway is a manufacturer of smart vehicles focused on the truck freight market, offering advanced intelligent driving solutions. The company designs heavy-duty trucks characterized by low wind resistance and high-level intelligent driving capabilities. Its vehicles feature a distributed drive system with a modular design that operates on a unified hydrogen and electricity platform. This innovative approach allows the logistics industry to leverage smart freight systems, enhancing efficiency and sustainability in transportation.

Insilico Medicine

Series D in 2022
Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.

Biren Technology

Series B in 2022
Biren Technology is a high-tech startup specializing in the design and development of intelligent processors tailored for GPU and DSA computation architectures. The company focuses on creating integrated software and hardware platforms that support intelligent computing applications, including cloud computing, artificial intelligence training, graphics rendering, and high-performance general-purpose computing. With a dedicated team of industry experts and elite engineers, Biren Technology aims to deliver versatile computing solutions that blend general computing capabilities with specific applications. Its research division is committed to advancing key technologies in intelligent computing systems, emphasizing new architectures and advanced compilation techniques, thereby facilitating technological breakthroughs in various high-tech sectors.

Biotree Technology

Series A in 2022
Biotree is a high-tech enterprise focused on the application and development of advanced research technology in the life sciences sector. It specializes in metabolomics, offering early detection and analysis services in China. The company boasts a core team with significant expertise in metabolomics, encompassing scientific research services, health testing, and industrial testing. Biotree emphasizes mass spectrometry and metabolic testing, continually innovating in metabolomics products and technologies. It holds several patents in this field and is recognized for its accomplishments in metabolomics detection and analysis. Over the years, Biotree has demonstrated consistent growth and has maintained profitability for six consecutive years, solidifying its position in the biotechnological testing and consulting services market.

Insilico Medicine

Series D in 2022
Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.

Ashermed

Series B in 2022
Ashermed is a provider of contract research organization (CRO) services tailored for medical companies. The company emphasizes the integration of advanced technologies, including Internet technology, big data, and artificial intelligence, into its offerings. By doing so, Ashermed aims to help medical companies shorten the drug development cycle, enhance the quality of clinical data, and lower research and development costs. Their services encompass CRO, site management organization (SMO), patient recruitment, and digital platform support, positioning them as a comprehensive partner in the medical research industry.

Rhino Federated Computing

Venture Round in 2022
The value of connecting disparate datasets is immense, yet much of this potential remains untapped. Imagine the transformative possibilities: pharmaceutical companies sharing data to design better drugs and evaluate their real-world value, hospitals and HMOs diagnosing rare diseases faster, or financial institutions collaborating to combat financial crime. Rhino Federated Computing makes this vision a reality. Our federated computing platform, powered by advanced edge-computing and federated learning technologies, enables organizations to train and deploy AI models on massive, distributed datasets—without sharing sensitive information or compromising data privacy and sovereignty. This breakthrough approach was pioneered by our co-founder and CEO, Dr. Ittai Dayan, a recognized leader in the field whose work includes a landmark Nature Medicine publication in 2021.

HOUMO.AI

Series A in 2022
Houmo.AI is a semiconductor company founded in 2020 by Dr. Wu Qiang, specializing in integrated circuit storage technology tailored for artificial intelligence and high-power computing applications. The company focuses on developing intelligent computing chips that cater to the growing demand for computing power in the AI sector. By leveraging innovative technologies, Houmo.AI aims to deliver chips that offer significant performance improvements while maintaining low power consumption and affordability. This approach enables enterprises to manufacture advanced intelligent robotics and other AI-integrated electronics, ultimately striving to meet the challenges of true artificial intelligence.

Vistel

Series B in 2022
Vistel is a technology company founded in 2016 by Sun Yuhui and Ding Dayong, specializing in the application of artificial intelligence in the medical field. The firm focuses on developing AI-driven ophthalmic medical imaging technology designed to enhance the diagnosis of eye diseases. By utilizing advanced diagnostic systems that incorporate computer vision processing and image annotation, Vistel aims to provide medical practitioners with innovative tools for the digital analysis and management of patients' eye conditions.

Zhipu AI

Series B in 2022
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

Prime Lifescience

Seed Round in 2022
Prime Lifescience is a developer of a big data platform tailored for the life sciences sector. The company focuses on creating a health lifecycle big data collaboration network through innovative digital technologies and the application of artificial intelligence. Prime Lifescience offers a range of services, including a digital smart health community, a digital intelligent clinical research accelerator, and a live big data platform. These offerings aim to enhance digital clinical research and foster a comprehensive medical solutions framework within the healthcare industry, leveraging extensive data to improve health outcomes.

Axera

Series A in 2022
Axera is a high-tech semiconductor company specializing in the development of advanced artificial intelligence (AI) System-on-Chips (SoCs) for computer applications. The company's flagship product is an AI chip designed to excel in visual processing tasks, offering superior performance at low power consumption and latency, while maintaining high integration capabilities. This enables clients to perform real-time video analysis on devices, capture high-quality videos, and integrate multiple cameras efficiently with reduced costs.

Tungee

Series B in 2021
Tungee, established in 2016, is a provider of intelligent sales solutions for business-to-business enterprises. By utilizing big data and artificial intelligence technologies, including natural language processing and machine learning, Tungee offers a comprehensive platform that facilitates lead mining, business opportunity engagement, customer relationship management, and order analysis. This platform is designed to help enterprises efficiently identify, contact, and manage customers, thereby reducing customer acquisition costs and enhancing overall sales performance. Tungee has positioned itself as a leader in the Chinese intelligent sales sector, serving over 3,000 enterprise clients, including notable companies such as Alibaba and China Mobile. Through its innovative approach, Tungee addresses the challenges faced by businesses in sales forecasting and customer management.

DP Technology

Series B in 2021
DP Technology is a global leader in the "AI for Science" research paradigm, where AI learns scientific principles and data, then tackles key challenges in scientific research and industrial R&D. DP's commitment to interdisciplinary research has led to the creation of the DP "Particle Universe", an array of pre-trained large science models designed to bridge foundational research with practical industrial applications. DP's software suite includes the Bohrium® Scientific Research Space, Hermite® Computational Drug Design Platform, RiDYMO® Dynamics Platform, and Piloteye® Battery Design Automation Platform. Together, these platforms form a robust foundation for industrial innovation and an open ecosystem for AI in science, fostering advancements in key areas such as drug discovery, energy, material science, and information technology.

Frontis

Seed Round in 2021
Frontis provides artificial intelligence technology solutions focused on demand planning and product performance monitoring. The company specializes in 3C product planning, marketing strategies, and digital transformation services, catering primarily to the fast-moving consumer goods (FMCG), 3C, and beauty sectors. By leveraging advanced technology, Frontis aids businesses in forecasting product demand and understanding consumer needs, thereby enhancing their ability to connect with customers and create value.

Gemsouls

Series A in 2021
Gemsouls is a developer of an artificial intelligence platform that enables virtual characters to interact with the real world. The company aims to create an innovative experience for fans, allowing them to engage with their favorite characters and maintain lasting connections with both fictional and real-life figures. By leveraging AI technology, Gemsouls facilitates meaningful interactions, enhancing the ways individuals can relate to and enjoy their beloved characters.

Bioyond Tech

Seed Round in 2021
Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

Zeen Health

Venture Round in 2021
Zeen Health is a digital therapeutics company that specializes in providing personalized mental health services through a mobile application. Founded in 2019 and headquartered in Shenzhen, China, the company utilizes artificial intelligence technology to deliver evidence-based mental health solutions. By focusing on the individual needs of users, Zeen Health aims to improve mental wellness through innovative digital approaches.

Lingyi Zhihui

Series B in 2021
Zuoshouyisheng's AI ​​doctor platform spans 35 medical specialties and can diagnose more than 6,000 diseases, according to the company’s website. Zuoshouyisheng mainly collaborates with customers through a SaaS business model, providing its AI-empowered healthcare system to hospitals, pharmaceutical companies, employers, and insurers.

HOUMO.AI

Seed Round in 2021
Houmo.AI is a semiconductor company founded in 2020 by Dr. Wu Qiang, specializing in integrated circuit storage technology tailored for artificial intelligence and high-power computing applications. The company focuses on developing intelligent computing chips that cater to the growing demand for computing power in the AI sector. By leveraging innovative technologies, Houmo.AI aims to deliver chips that offer significant performance improvements while maintaining low power consumption and affordability. This approach enables enterprises to manufacture advanced intelligent robotics and other AI-integrated electronics, ultimately striving to meet the challenges of true artificial intelligence.

Insilico Medicine

Series C in 2021
Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.

Tungee

Series C in 2021
Tungee, established in 2016, is a provider of intelligent sales solutions for business-to-business enterprises. By utilizing big data and artificial intelligence technologies, including natural language processing and machine learning, Tungee offers a comprehensive platform that facilitates lead mining, business opportunity engagement, customer relationship management, and order analysis. This platform is designed to help enterprises efficiently identify, contact, and manage customers, thereby reducing customer acquisition costs and enhancing overall sales performance. Tungee has positioned itself as a leader in the Chinese intelligent sales sector, serving over 3,000 enterprise clients, including notable companies such as Alibaba and China Mobile. Through its innovative approach, Tungee addresses the challenges faced by businesses in sales forecasting and customer management.

CastBox

Series C in 2021
CastBox is a spoken audio platform founded in 2016 and based in Beijing, China, with additional offices in Hong Kong and San Francisco. The platform allows users to easily find, access, and enjoy a wide range of spoken audio content, including podcasts, on-demand radio, and audiobooks, across multiple devices such as mobile phones, desktops, and smart home devices. CastBox employs proprietary technology, including curated podcast recommendations and an in-audio deep search feature powered by natural language processing and machine learning. This technology enables the platform to deliver personalized listening experiences tailored to individual user preferences and habits. The service is available in multiple languages, making it accessible to a global audience.

Xizi Education

Series A in 2021
Xizhi Education (Beijing Xizi Education Technology Co., Ltd.) is a leading enterprise in artificial intelligence empowerment education. The headquarters is located in Zhizhi Street, Zhongguancun, which is known as the “China Silicon Valley”. As one of the key incubators of Tsinghua University, from the aspects of policy, capital and talents, it has been strongly supported by Tsinghua's three innovation and entrepreneurship platforms iCenter, Chuang+ and xlab, and won the honor of Zhongguancun High-tech Enterprise.

Unisound

Series D in 2021
Beijing Yunzhisheng Information Technology Co., Ltd., also known as Unisound, is a Chinese startup established in June 2012, specializing in intelligent voice and speech processing technologies. The company has developed proprietary speech recognition technologies and utilizes cloud computing to deliver a range of middleware and cloud platforms for speech recognition services. Unisound's offerings cater to both internet enterprises and individual users, providing professional solutions for voice recognition. The core technology team is composed of highly qualified professionals, with over 80% holding doctoral degrees and possessing extensive experience in voice recognition research and development. Additionally, Unisound focuses on Internet of Things (IoT) and artificial intelligence (AI) technologies, enabling efficient communication between users and machines through voice commands, thereby minimizing the need for manual input.

Axera

Seed Round in 2021
Axera is a high-tech semiconductor company specializing in the development of advanced artificial intelligence (AI) System-on-Chips (SoCs) for computer applications. The company's flagship product is an AI chip designed to excel in visual processing tasks, offering superior performance at low power consumption and latency, while maintaining high integration capabilities. This enables clients to perform real-time video analysis on devices, capture high-quality videos, and integrate multiple cameras efficiently with reduced costs.

Hangzhou Weier

Series B in 2021
Hangzhou Weier Technology Co., Ltd, also known as Weier Science, specializes in the design and development of robots and software that enhance human-machine interaction. Founded in 2016 and headquartered in Hangzhou, China, the company operates within the augmented and virtual reality sectors. Weier Technology focuses on artificial intelligence and natural language processing to create customer service robots that assist e-commerce platforms. These robots can answer customer inquiries, generate customer profiles, and analyze data to improve service delivery, ultimately helping businesses better understand and engage with their clients.

Vistel

Series B in 2021
Vistel is a technology company founded in 2016 by Sun Yuhui and Ding Dayong, specializing in the application of artificial intelligence in the medical field. The firm focuses on developing AI-driven ophthalmic medical imaging technology designed to enhance the diagnosis of eye diseases. By utilizing advanced diagnostic systems that incorporate computer vision processing and image annotation, Vistel aims to provide medical practitioners with innovative tools for the digital analysis and management of patients' eye conditions.

TutorEva

Venture Round in 2021
TutorEva is an educational technology application that offers online tutoring services through an innovative platform. Users can scan arithmetic problems and receive solutions in various formats, including text, illustrations, and voice instructions. The application utilizes artificial intelligence to effectively solve mathematical problems, thereby assisting students and users in understanding and resolving their math-related queries. By combining technology with educational support, TutorEva aims to enhance the learning experience and facilitate easier access to tutoring resources.

Shukun

Series B in 2020
Shukun Technology is a Chinese healthcare company founded in 2017 and headquartered in Beijing. It specializes in developing diagnostic systems that leverage machine learning and artificial intelligence to detect cardiovascular diseases and tumors. By employing deep learning algorithms, Shukun Technology intelligently analyzes medical images to automatically identify lesions and generate comprehensive reports. The company's innovations aim to enhance the efficiency of medical professionals, ultimately improving the quality of diagnosis and treatment in primary healthcare settings.

Tungee

Series B in 2020
Tungee, established in 2016, is a provider of intelligent sales solutions for business-to-business enterprises. By utilizing big data and artificial intelligence technologies, including natural language processing and machine learning, Tungee offers a comprehensive platform that facilitates lead mining, business opportunity engagement, customer relationship management, and order analysis. This platform is designed to help enterprises efficiently identify, contact, and manage customers, thereby reducing customer acquisition costs and enhancing overall sales performance. Tungee has positioned itself as a leader in the Chinese intelligent sales sector, serving over 3,000 enterprise clients, including notable companies such as Alibaba and China Mobile. Through its innovative approach, Tungee addresses the challenges faced by businesses in sales forecasting and customer management.

Biren Technology

Series A in 2020
Biren Technology is a high-tech startup specializing in the design and development of intelligent processors tailored for GPU and DSA computation architectures. The company focuses on creating integrated software and hardware platforms that support intelligent computing applications, including cloud computing, artificial intelligence training, graphics rendering, and high-performance general-purpose computing. With a dedicated team of industry experts and elite engineers, Biren Technology aims to deliver versatile computing solutions that blend general computing capabilities with specific applications. Its research division is committed to advancing key technologies in intelligent computing systems, emphasizing new architectures and advanced compilation techniques, thereby facilitating technological breakthroughs in various high-tech sectors.

Shukun

Series B in 2020
Shukun Technology is a Chinese healthcare company founded in 2017 and headquartered in Beijing. It specializes in developing diagnostic systems that leverage machine learning and artificial intelligence to detect cardiovascular diseases and tumors. By employing deep learning algorithms, Shukun Technology intelligently analyzes medical images to automatically identify lesions and generate comprehensive reports. The company's innovations aim to enhance the efficiency of medical professionals, ultimately improving the quality of diagnosis and treatment in primary healthcare settings.

NVX Clouds Tech

Series A in 2020
NVX Clouds Tech is an artificial intelligence security computing company focused on data privacy protection. It utilizes unique privacy computing technology to fully protect local and cloud data privacy and security through the Cing Weixin privacy cloud computing platform and all-in-one product line. It also provides solutions for the protection of big data security and commercial secrets in finance. The company aims to build a privacy computing platform for big data, separate the ownership, management, and use rights of the data, fully realize the flow of data, and promote the fourth industrial revolution.

Genius

Series B in 2019
Genius, founded in February 2017, specializes in K12 artificial intelligence education. The company develops a STEAM education curriculum and technology, designing courses and projects that cover digital modeling, robotics, programming, and entrepreneurship. These resources are intended for educators to implement in their classrooms, empowering students to engage with and contribute to future technological innovations.

TigerGraph

Series B in 2019
TigerGraph Inc. develops a graph analytics platform that facilitates advanced analytics and machine learning on connected data. Founded in 2012 and headquartered in Redwood City, California, the company also has offices in Shanghai, London, and Munich. Its platform features a distributed native graph database, enabling real-time graph updates and built-in parallel computation. TigerGraph's technology supports various applications, including fraud detection, anti-money laundering, customer 360 analysis, recommendations, and network analysis. By transforming complex data into a network of objects and relationships, the platform empowers enterprises to uncover hidden patterns and derive actionable insights, enhancing their relationship analysis capabilities.

Insilico Medicine

Series B in 2019
Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.

Huimei Technology

Series C in 2019
Huimei Technology specializes in developing and designing artificial intelligence solutions aimed at enhancing clinical quality in healthcare. The company’s core offerings include a single disease process quality management system and a Clinical Decision Support System (CDSS) that integrates an evidence-based medical knowledge base. Utilizing advanced techniques such as natural language processing and deep learning, Huimei Technology processes clinical big data to provide real-time decision-making assistance for healthcare professionals. This integration of standard electronic clinical pathways and workflows allows clinicians to deliver more personalized and effective diagnoses and treatment plans based on individual patient conditions. The company's products are primarily targeted for use in outpatient, emergency, and inpatient settings within large hospitals, ultimately aiming to improve patient outcomes and the overall efficiency of medical services.

Tungee

Series B in 2019
Tungee, established in 2016, is a provider of intelligent sales solutions for business-to-business enterprises. By utilizing big data and artificial intelligence technologies, including natural language processing and machine learning, Tungee offers a comprehensive platform that facilitates lead mining, business opportunity engagement, customer relationship management, and order analysis. This platform is designed to help enterprises efficiently identify, contact, and manage customers, thereby reducing customer acquisition costs and enhancing overall sales performance. Tungee has positioned itself as a leader in the Chinese intelligent sales sector, serving over 3,000 enterprise clients, including notable companies such as Alibaba and China Mobile. Through its innovative approach, Tungee addresses the challenges faced by businesses in sales forecasting and customer management.

Mech-Mind Robotics

Series A in 2019
Mech-Mind Robotics Technologies, founded in 2016 and based in Beijing, China, specializes in manufacturing smart cameras and developing AI-powered software for the logistics industry. The company produces a range of cameras, including the Mech-Eye Smart Camera, designed for tasks such as object recognition, depalletizing, assembly, sorting, and locating. Mech-Mind's technology integrates 3D vision with artificial intelligence, enabling robots to recognize objects of various shapes and sizes. With over 10,000 cameras deployed across more than 50 countries, Mech-Mind Robotics supports partners and system integrators in addressing complex automation challenges, including logistics parcel picking and related operations. The company also maintains an office in Munich, Germany, and a sales office in Shanghai, China.

Emergen

Series B in 2019
Emergen, operated by Zhejiang Zhichang Group, focuses on the development and manufacturing of intelligent robots and comprehensive manufacturing solutions. The company has developed two core technologies: a distributed intelligent robot controller and an HCPS intelligent intellectual network. These innovations support high-performance robotic systems and industrial solutions that are integral to smart factory construction. Emergen’s products enable closed-loop control of process data, ensuring traceability of quality information and facilitating intelligent logistics management. By concentrating on creating robotic products with independent intellectual property rights, the company aims to reduce reliance on foreign brands in critical components of robotics, contributing to the advancement of intelligent manufacturing in China.

ABC Fintech

Series B in 2018
ABC Fintech provides AI-driven cloud services for financial professionals. Its products, Modeling.ai and Eversight.ai, can improve the efficiency of how equity research and investment decisions are made in financial institutions, as well as to predict future trend. The company was founded in 2016 by Yongzhi Yang, who is also the founder and CEO of MoboTap Inc, the company behind Dolphin Browser. So far, ABC Fintech has raised a total of $60 million USD from Qiming Venture Partners, Source Code Capital, SIG Asia Investment, Welight Capital, and MindWorks Ventures.

Eigen

Series B in 2018
Eigen Technologies, Inc. is a provider of artificial intelligence services based in Hangzhou, China. The company focuses on applying advanced AI technologies across various business domains, emphasizing natural language understanding, knowledge graphs, and deep learning. By leveraging these technologies, Eigen aims to enhance user experiences and drive innovation, offering industries solutions for big data analysis rooted in artificial intelligence.

Tungee

Series A in 2018
Tungee, established in 2016, is a provider of intelligent sales solutions for business-to-business enterprises. By utilizing big data and artificial intelligence technologies, including natural language processing and machine learning, Tungee offers a comprehensive platform that facilitates lead mining, business opportunity engagement, customer relationship management, and order analysis. This platform is designed to help enterprises efficiently identify, contact, and manage customers, thereby reducing customer acquisition costs and enhancing overall sales performance. Tungee has positioned itself as a leader in the Chinese intelligent sales sector, serving over 3,000 enterprise clients, including notable companies such as Alibaba and China Mobile. Through its innovative approach, Tungee addresses the challenges faced by businesses in sales forecasting and customer management.

AI Prime

Series A in 2018
AI-Prime is a company based in Shanghai, China, that specializes in artificial intelligence-driven safety solutions for industrial environments. It offers a cloud-based software-as-a-service platform that integrates with camera systems to enhance workplace safety. The company's technology focuses on identifying direct threats and provides data-driven insights and reports that facilitate a continuous feedback loop. This approach enables various industries to automate safety measures and improve operational efficiency. AI-Prime's commitment to creating safer working environments positions it as a key player in the field of industrial security solutions.

Philm

Series B in 2018
Philm is a camera-first social messaging application developed by Yoyo Visual World Co., Ltd., which specializes in photo and video editing. Launched in October 2016, Philm allows users to apply real-time art filters and motion-tracking stickers to their videos, transforming everyday moments into animated works of art. Utilizing AI and deep learning technologies, the app captures the artistic styles of various paintings, enabling users to create unique video clips that reflect these styles. The application also features pinnable and resizable emoji stickers that adapt to the movements and orientation of the objects they are attached to. Philm's services are commercialized through partnerships with corporations and intellectual property brands, enhancing its reach and functionality. Based in China, Yoyo Visual World continues to innovate in the realm of creative digital tools.

The Makers

Series B in 2018
The Makers is a technology-focused media content provider based in China, specializing in a platform that facilitates the sharing of technology and innovation. The company is dedicated to promoting robotics competition and entertainment, most notably through its signature show, King of Bots. This initiative positions The Makers at the forefront of the growing interest in robotics and related technologies, appealing to both enthusiasts and the general public. By combining media and technology, The Makers aims to lead trends in this dynamic sector.

CastBox

Series B in 2018
CastBox is a spoken audio platform founded in 2016 and based in Beijing, China, with additional offices in Hong Kong and San Francisco. The platform allows users to easily find, access, and enjoy a wide range of spoken audio content, including podcasts, on-demand radio, and audiobooks, across multiple devices such as mobile phones, desktops, and smart home devices. CastBox employs proprietary technology, including curated podcast recommendations and an in-audio deep search feature powered by natural language processing and machine learning. This technology enables the platform to deliver personalized listening experiences tailored to individual user preferences and habits. The service is available in multiple languages, making it accessible to a global audience.

Infervision

Series B in 2018
Infervision is an artificial intelligence company based in Beijing that specializes in medical imaging diagnosis. Utilizing deep learning technology and computer vision, Infervision develops innovative solutions to assist in the diagnosis of cancers and other medical conditions. The company launched the world's first artificial intelligence precise healthcare platform and has introduced intelligent X-ray and CT diagnosis products, which are currently undergoing trials in several prominent hospitals in China. Infervision collaborates closely with top medical institutions, fostering strong partnerships with nearly 20 Tertiary Grade A hospitals, including Peking Union Medical College Hospital and Tongji Medical College. This collaboration aims to enhance the integration of medical data, technology, and application scenarios, ultimately providing more accurate and efficient diagnostic tools for healthcare professionals. Through its research and development efforts, Infervision is committed to advancing the field of artificial intelligence in healthcare, thereby improving patient outcomes and reducing costs.

BingoBox

Series B in 2018
BingoBox is an innovative convenience store concept in China that operates on a largely automated model, eliminating the need for on-site staff. The store offers a variety of daily essentials, including snacks and beverages, catering to late-night shoppers. Customers enter the store by scanning a QR code and can make payments through mobile platforms. To prevent theft, BingoBox employs advanced sensors and technology to track products selected by customers, ensuring that all items are paid for. Although the store is predominantly unmanned, it provides remote customer service and is restocked daily, combining elements of artificial intelligence and smart technology to enhance the shopping experience and reduce operational costs.

XiaoMan Technology

Series C in 2018
Xiaoman Technology, established in 2013 and based in Shenzhen, China, specializes in providing foreign trade solutions that leverage big data and artificial intelligence. The company develops SaaS-based business management services that encompass customer relationship management, marketing, sales management, and other core business functions. Its offerings are designed to be flexible and compatible, catering to the standardization needs of small and micro enterprises while also addressing the customization requirements of larger organizations. By focusing on comprehensive customer-oriented research and development, as well as effective sales, marketing, and service strategies, Xiaoman Technology aims to enhance customer service, improve sales productivity, and help businesses expand their international operations.

Eigen

Series B in 2017
Eigen Technologies, Inc. is a provider of artificial intelligence services based in Hangzhou, China. The company focuses on applying advanced AI technologies across various business domains, emphasizing natural language understanding, knowledge graphs, and deep learning. By leveraging these technologies, Eigen aims to enhance user experiences and drive innovation, offering industries solutions for big data analysis rooted in artificial intelligence.

CastBox

Series A in 2017
CastBox is a spoken audio platform founded in 2016 and based in Beijing, China, with additional offices in Hong Kong and San Francisco. The platform allows users to easily find, access, and enjoy a wide range of spoken audio content, including podcasts, on-demand radio, and audiobooks, across multiple devices such as mobile phones, desktops, and smart home devices. CastBox employs proprietary technology, including curated podcast recommendations and an in-audio deep search feature powered by natural language processing and machine learning. This technology enables the platform to deliver personalized listening experiences tailored to individual user preferences and habits. The service is available in multiple languages, making it accessible to a global audience.

Infervision

Series B in 2017
Infervision is an artificial intelligence company based in Beijing that specializes in medical imaging diagnosis. Utilizing deep learning technology and computer vision, Infervision develops innovative solutions to assist in the diagnosis of cancers and other medical conditions. The company launched the world's first artificial intelligence precise healthcare platform and has introduced intelligent X-ray and CT diagnosis products, which are currently undergoing trials in several prominent hospitals in China. Infervision collaborates closely with top medical institutions, fostering strong partnerships with nearly 20 Tertiary Grade A hospitals, including Peking Union Medical College Hospital and Tongji Medical College. This collaboration aims to enhance the integration of medical data, technology, and application scenarios, ultimately providing more accurate and efficient diagnostic tools for healthcare professionals. Through its research and development efforts, Infervision is committed to advancing the field of artificial intelligence in healthcare, thereby improving patient outcomes and reducing costs.

TigerGraph

Series A in 2017
TigerGraph Inc. develops a graph analytics platform that facilitates advanced analytics and machine learning on connected data. Founded in 2012 and headquartered in Redwood City, California, the company also has offices in Shanghai, London, and Munich. Its platform features a distributed native graph database, enabling real-time graph updates and built-in parallel computation. TigerGraph's technology supports various applications, including fraud detection, anti-money laundering, customer 360 analysis, recommendations, and network analysis. By transforming complex data into a network of objects and relationships, the platform empowers enterprises to uncover hidden patterns and derive actionable insights, enhancing their relationship analysis capabilities.

Sino Vision

Series B in 2017
SinoVision is a medical device manufacturing company based in China, established in 2012. It specializes in the development of computed tomography (CT) scanners, offering a range of products including 16-Slice, 32-Slice, and 64-Slice CT scanners. The company also provides advanced technologies such as the sROBOT robot CT navigation system and sAI intelligent imaging solutions. SinoVision holds intellectual property for CT detectors and designs X-ray tubes and high-voltage power supplies specifically for CT scanners. Additionally, it operates a cloud diagnosis platform that integrates CT image post-processing workstations with an online consultation platform, facilitating comprehensive imaging diagnoses for healthcare professionals and institutions.

ABC Fintech

Series A in 2017
ABC Fintech provides AI-driven cloud services for financial professionals. Its products, Modeling.ai and Eversight.ai, can improve the efficiency of how equity research and investment decisions are made in financial institutions, as well as to predict future trend. The company was founded in 2016 by Yongzhi Yang, who is also the founder and CEO of MoboTap Inc, the company behind Dolphin Browser. So far, ABC Fintech has raised a total of $60 million USD from Qiming Venture Partners, Source Code Capital, SIG Asia Investment, Welight Capital, and MindWorks Ventures.

Kuaile Zhihui

Series A in 2017
Kuaile Zhihui, which means “happiness and intelligence”, is a Beijing-based artificial intelligence start-up developing educational robots for children. The company develops educational robots for kindergarten and primary school students, employing speech recognition, big data analysis, and deep learning. Its robots teach math, Chinese and English, and can adjust course content by evaluating a child’s learning ability based on its big data analysis system. Kuaile Zhihui was founded in 2015 by Lei Ming, former chief architect at Baidu Inc. and founder of music site Kuwo.

BingoBox

Series A in 2017
BingoBox is an innovative convenience store concept in China that operates on a largely automated model, eliminating the need for on-site staff. The store offers a variety of daily essentials, including snacks and beverages, catering to late-night shoppers. Customers enter the store by scanning a QR code and can make payments through mobile platforms. To prevent theft, BingoBox employs advanced sensors and technology to track products selected by customers, ensuring that all items are paid for. Although the store is predominantly unmanned, it provides remote customer service and is restocked daily, combining elements of artificial intelligence and smart technology to enhance the shopping experience and reduce operational costs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.